𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

✍ Scribed by Eleni Tholouli; Effie Liakopoulou; Hayley M. Greenfield; Bronwen E. Shaw; Sudhir Tauro; Jennifer L. Byrne; Mike Dennis; John Burthem; Guy S. Lucas; Charles Craddock; Nigel H. Russell; John A. Liu Yin


Book ID
108675797
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
126 KB
Volume
142
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES